Public list: BIO 2016 (619) Pharma Startups (6570)

Alcobra is a pharmaceutical company committed to developing safe and effective products for the treatment of cognitive disorders including ADHD and Fragile X Syndrom.

Alcobra is a pharmaceutical company committed to developing safe and effective products for the treatment of cognitive disorders including ADHD and Fragile X Syndrom.

Company (IPO / Went public)

Phone: +972 722204661

Fax:

Azrieli Triangle Building 39th Floor
132 Derech Menachem Begin
6701101
Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Alcobra $40M Nov 17, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Alcobra Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Abuse deterrent formulations of amphetamine May 10, 2017 Apr 03, 2018 Patent
Methods of treating fragile x syndrome and related disorders Sep 09, 2014 Dec 26, 2017 Patent
Methods of determining response to therapy Sep 09, 2014 Dec 26, 2017 Patent
Method for decreasing symptoms of alcohol consumption Apr 03, 2015 Nov 07, 2017 Patent
Substituted pyridoxine-lactam carboxylate-salts Oct 03, 2014 Aug 30, 2016 Patent
See all 11 patents